semaglutide for aud The connection between GLP1s and addiction/reward is fascinating. This is the first randomized controlled trial showing reduced excessive alcohol drinking with the drug Semaglutide – BIO PERFORMANCE LABS – Ozempic shown to reduce drinking

Lixisenatide: A new daily GLP-1 agonist for type 2 diabetes management

Study-specific OR estimates were pooled using either a fixed-effects model or a random-effects model in case a significant heterogeneity exists

Best of all, none of the patients reported relevant side effects, either during or after the treatment

On the other side, there are isolated reports that hint at potential harm to the liver

#FDA #drugs #pharma #PreCheck #drugreviews #regulation #listennow Michael Levin-Epstein To view or add a comment, sign in | The exponential growth of the 340B Drug Pricing Program has contributed to its many challenges, including duplicative payments